(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with dronabinol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Blond, O; Briley, EM; Felder, CC; Joyce, KE; Lai, Y; Ma, AL; Mackie, K; Mansouri, J; Mitchell, RL | 1 |
| Abood, ME; Compton, DR; Martin, BR; Showalter, VM | 1 |
| Bianchi, A; Cruciani, G; Fichera, M; Musumarra, G | 1 |
| Almond, A; Bushell, K; Cassidy, MP; He, H; Huffman, JW; Martin, BR; Selley, DE; Szklennik, PV; Wiley, JL | 1 |
| Fowler, CJ; Lambert, DM | 1 |
| Balaux, E; Boisvert, L; Brown, W; Cheng, YX; Godbout, C; Hodzic, L; Liu, Z; Luo, X; Milburn, C; Pagé, D; Payza, K; Salois, D; Srivastava, S; St-Onge, S; Tomaszewski, M; Tremblay, M; Walpole, C; Wei, Z; Woo, S; Yang, H; Zhou, F | 1 |
| Debonsi, HM; Di Marzo, V; Gerwick, WH; Gutiérrez, M; Ligresti, A; Pereira, AR | 1 |
| Chen, J; Huffman, JW; Martin, BR; Smith, VJ; Wiley, JL | 1 |
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Chicca, A; Curini, M; Gertsch, J; Messina, F; Pelosi, A; Petrucci, V; Rosati, O | 1 |
| Allarà, M; Di Marzo, V; Escobar, R; Faúndez, M; Iturriaga-Vásquez, P; Mella-Raipán, J; Palmieri, V; Pessoa-Mahana, CD; Pessoa-Mahana, H; Romero-Parra, J; Torres, MJ | 1 |
| Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
| Burstein, SH | 1 |
| Belardo, C; Cannazza, G; Citti, C; Forni, F; Gigli, G; Laganà, A; Linciano, P; Luongo, L; Maione, S; Montone, CM; Vandelli, MA | 1 |
4 review(s) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and dronabinol
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
Eicosanoid mediation of cannabinoid actions.
Topics: Cannabinoids; Eicosanoids; Humans | 2019 |
10 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and dronabinol
| Article | Year |
|---|---|
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Amidohydrolases; Animals; Arachidonic Acids; Base Sequence; Binding, Competitive; Calcium; Calcium Channel Blockers; Cannabinoids; CHO Cells; Cricetinae; Endocannabinoids; Enzyme Activation; Humans; Intracellular Fluid; Ion Channels; Kinetics; Mice; Molecular Sequence Data; Phospholipases; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Transfection | 1995 |
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Topics: Animals; Binding, Competitive; Brain; Cannabinoids; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Cyclohexanols; Guanine Nucleotides; Humans; Ligands; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; Sodium; Structure-Activity Relationship; Transfection | 1996 |
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
Topics: Arachidonic Acids; Cannabinoids; Drug Design; Endocannabinoids; Indoles; Ligands; Models, Biological; Models, Molecular; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 2000 |
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
Topics: Acetylation; Biomimetic Materials; Cannabinoids; Indoles; Molecular Structure; Pentanes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2005 |
Novel benzimidazole derivatives as selective CB2 agonists.
Topics: Benzimidazoles; Binding, Competitive; Cannabinoid Receptor Modulators; Cannabinoids; Chemistry, Pharmaceutical; Drug Design; Humans; Models, Chemical; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Structure-Activity Relationship; Technology, Pharmaceutical | 2008 |
Cannabinomimetic lipid from a marine cyanobacterium.
Topics: Cyanobacteria; Dose-Response Relationship, Drug; Humans; Lipids; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Panama; Papua New Guinea; Receptor, Cannabinoid, CB1 | 2011 |
Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents.
Topics: Animals; Halogenation; Indoles; Male; Mice; Motor Activity; Naphthalenes; Receptors, Cannabinoid; Structure-Activity Relationship | 2012 |
One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Topics: Chemistry Techniques, Synthetic; Dronabinol; Humans; Microwaves; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substrate Specificity; Xanthenes | 2014 |
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Drug Design; Humans; Molecular Docking Simulation; Protein Binding; Protein Conformation; Receptor, Cannabinoid, CB2; Thiophenes | 2016 |
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Mice; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |